These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 327161
1. Pathogenic factors involved in renovascular hypertension. State of the art. Bumpus FM, Khosla MC. Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161 [Abstract] [Full Text] [Related]
2. Renin--angiotensin antagonists and the regulation of blood pressure. Samuels AI, Miller ED, Fray JC, Haber E, Barger AC. Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095 [Abstract] [Full Text] [Related]
4. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog. Bravo EL, Khosla MC, Bumpus FM. Prog Biochem Pharmacol; 1976 Nov; 12():33-40. PubMed ID: 1019168 [Abstract] [Full Text] [Related]
6. The use of saralasin to evaluate the function of the brain renin-angiotensin system. Reid IA. Prog Biochem Pharmacol; 1976 Nov; 12():117-34. PubMed ID: 1019160 [Abstract] [Full Text] [Related]
8. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE. Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [Abstract] [Full Text] [Related]
14. Inhibition of the pressor and aldosterone-releasing effects of angiotensin II. Bumpus FM, Khosla MC. Clin Sci Mol Med Suppl; 1975 Jun; 2():15s-18s. PubMed ID: 1077765 [Abstract] [Full Text] [Related]
15. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. Yamamoto T, Doi K, Ogihara T, Ichihara K, Hata T, Kumahara Y. Prog Biochem Pharmacol; 1976 Jun; 12():174-89. PubMed ID: 1019163 [Abstract] [Full Text] [Related]
16. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system. Atlas SA, Volpe M, Sosa RE, Laragh JH, Camargo MJ, Maack T. Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120 [Abstract] [Full Text] [Related]
17. Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis. Atlas SA, Laragh JH. Annu Rev Med; 1986 Jun; 37():397-414. PubMed ID: 2939792 [Abstract] [Full Text] [Related]
18. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF, Russell GI, Swales JD, Thurston H. J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [Abstract] [Full Text] [Related]
19. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM. Prog Biochem Pharmacol; 1976 Aug; 12():230-41. PubMed ID: 1019166 [Abstract] [Full Text] [Related]
20. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats. Campbell WB, Schmitz JM, Itskovitz HD. Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407 [Abstract] [Full Text] [Related] Page: [Next] [New Search]